Study compares single-inhaler triple therapies for treatment of COPD

by

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to a study published online Dec. 30 in The BMJ.

Leave A Comment

Your email address will not be published. Required fields are marked *